JAZZ - Jazz Pharmaceuticals Non-GAAP EPS of $3.95 misses by $0.27 revenue of $892.8M misses by $5.25M
2023-05-10 16:12:33 ET
- Jazz Pharmaceuticals press release ( NASDAQ: JAZZ ): Q1 Non-GAAP EPS of $3.95 misses by $0.27 .
- Revenue of $892.8M (+9.7% Y/Y) misses by $5.25M .
- FY23 Outlook: Revenue of $3675M-$3875M vs $3.79B consensus
For further details see:
Jazz Pharmaceuticals Non-GAAP EPS of $3.95 misses by $0.27, revenue of $892.8M misses by $5.25M